BlogMarch 21, 2023 George McBride, CCO of Clerkenwell Health, Sits in the Investor Hotseat on March 30th
BlogFebruary 16, 2023 Cody Shandraw, Founder of Healing REIT, Sits in the Investor Hotseat on February 23rd
BlogJanuary 10, 2023 Chad Harman, CEO of Psycheceutical, Sits in the Investor Hotseat on January 12th
BlogDecember 5, 2022 Joseph Tucker, CEO of Enveric Biosciences, Sits in the Investor Hotseat on December 8th
BlogNovember 18, 2022 Neil Markey, CEO of Beckley Retreats, Sits in the Investor Hotseat on November 23rd
BlogNovember 8, 2022 George Tziras, CEO of Small Pharma, Sits in the Investor Hotseat on November 10th
BlogNovember 3, 2022 How Can Businesses Take Advantage of Psychedelic Retreats?: Mindshifting Moments #16
BlogOctober 25, 2022 What are Some of the Most Common Misconceptions About Psychedelics?: Mindshifting Moments #15
BlogOctober 19, 2022 What Does the Future of Psychedelics Look Like?: A Mindshifting Moments Special Event
BlogOctober 7, 2022 Evan Levine, CEO of PsyBio Therapeutics, Sits in the Investor Hotseat on October 13th
BlogSeptember 28, 2022 What are the Concerns With Self-Administering Psychedelics?: Mindshifting Moments #12
BlogSeptember 27, 2022 Payton Nyquvest, CEO of Numinus, Sits in the Investor Hotseat on September 29th
